Institutional Ownership Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX). We have compiled data on the 1,830 institutions that hold shares in the stock, with a total of 233 Million shares, which have been reported (via 13F filing form) to have a value of $102 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Capital World Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
28,533,308
shares
|
$12.4 Billion
2.34% of portfolio
|
Q1 2025
Added 0.73%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
23,491,161
shares
|
$10.2 Billion
0.21% of portfolio
|
Q1 2025
Added 1.0%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,312,244
shares
|
$9.29 Billion
0.23% of portfolio
|
Q2 2024
Reduced 2.95%
|
|
Capital Research Global Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
14,536,344
shares
|
$6.34 Billion
1.6% of portfolio
|
Q1 2025
Added 39.38%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
11,788,657
shares
|
$5.14 Billion
0.24% of portfolio
|
Q1 2025
Reduced 1.59%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
7,755,645
shares
|
$3.38 Billion
0.29% of portfolio
|
Q1 2025
Added 22.85%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
5,761,760
shares
|
$2.51 Billion
0.23% of portfolio
|
Q1 2025
Added 2.01%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
5,454,748
shares
|
$2.38 Billion
0.53% of portfolio
|
Q1 2025
New holding
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
5,062,442
shares
|
$2.21 Billion
1.74% of portfolio
|
Q1 2025
Added 17.25%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
3,953,512
shares
|
$1.72 Billion
0.73% of portfolio
|
Q1 2025
Added 0.85%
|
|
Loomis Sayles & CO L P
|
May 14, 2025 Q1 2025 |
3,748,331
shares
|
$1.63 Billion
2.63% of portfolio
|
Q1 2025
Reduced 0.65%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
3,408,520
shares
|
$1.49 Billion
0.12% of portfolio
|
Q1 2025
Added 7.48%
|
|
Amundi
Paris, I0 |
May 15, 2025 Q1 2025 |
3,098,869
shares
|
$1.35 Billion
0.55% of portfolio
|
Q1 2025
Reduced 5.56%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,917,227
shares
|
$1.27 Billion
0.17% of portfolio
|
Q1 2025
Added 72.55%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
2,864,998
shares
|
$1.25 Billion
0.11% of portfolio
|
Q1 2025
Added 18.42%
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
2,747,937
shares
|
$1.2 Billion
0.76% of portfolio
|
Q1 2025
Reduced 3.03%
|
|
Edgewood Management LLC
Greenwich, CT |
May 14, 2025 Q1 2025 |
2,644,026
shares
|
$1.15 Billion
4.46% of portfolio
|
Q1 2025
Reduced 10.57%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
2,619,392
shares
|
$1.14 Billion
0.19% of portfolio
|
Q1 2025
Reduced 3.74%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
2,559,476
shares
|
$1.12 Billion
0.33% of portfolio
|
Q1 2025
Added 9.89%
|
|
Gamma Investing LLC
Foster City, CA |
Apr 07, 2025 Q1 2025 |
2,425,070
shares
|
$1.06 Billion
0.03% of portfolio
|
Q1 2025
Reduced 99.79%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
2,235,469
shares
|
$975 Million
0.3% of portfolio
|
Q1 2025
Added 10.91%
|
|
Massachusetts Financial Services CO
Boston, MA |
May 02, 2025 Q1 2025 |
2,024,908
shares
|
$883 Million
0.35% of portfolio
|
Q1 2025
Reduced 11.52%
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
1,894,169
shares
|
$826 Million
0.26% of portfolio
|
Q1 2025
Added 0.53%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
1,845,640
shares
|
$805 Million
0.18% of portfolio
|
Q1 2025
Reduced 2.78%
|
|
Parnassus Investments, LLC
|
May 14, 2025 Q1 2025 |
1,772,718
shares
|
$773 Million
2.18% of portfolio
|
Q1 2025
Reduced 2.38%
|